An epidermal growth factor (EGF) modified poly (lactic-co-glycolic acid) (PLGA) nanoparticle was loaded with 5-fluorouracil (5-FU) and perfluorocarbon (PFC) for a targeted treatment for CRC [100]. The gene discussed is EGF; the disease is colorectal carcinoma.